Dr Abd A Tahrani MD, MMedSci, CCT (Endocrinology and Diabetes), PhD, SCOPE (International Fellow), FRCP (London)

Dr Abd A Tahrani

Institute of Metabolism and Systems Research
Senior Lecturer in Metabolic Endocrinology and Obesity Medicine

Contact details

Address
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Abd Tahrani is a Senior Lecturer in Metabolic Endocrinology and Obesity Medicine at the University of Birmingham (UOB), and a Honorary Consultant Endocrinologist and Bariatric Physician and the lead for weight management research and diabetic neuropathy services at the University Hospitals Birmingham NHS Foundation Trust. Dr Tahrani is also the translational research lead at the Centre of Endocrinology, Diabetes and Metabolism, Birmingham Health Partners and the communication co-lead at the Institute of Metabolism and Systems Research

In addition, Dr. Tahrani has several national roles including: A trustee of the Association for the Study of Obesity (ASO) UK, the co-chair of the clinical practice and obesity management committee of the ASO UK, a member of the strategic council of the Obesity All Party Parliamentary Group (Obesity APPG), a member of the research committee of the British Sleep Society, an Expert and Clinical advisor to the National Institute for Health and Care Excellence (NICE), and a member of the National Institute for Health Research (NIHR) Research for Patients Benefit (RfPB) and the NIHR Dissemination Centre.

Obesity stigma: a key problem in tackling obesity

A recent report from the All-Party Parliamentary Group on Obesity showed that 88% of people with obesity have been stigmatised, criticised or abused because of their disease.

 

Qualifications

  • SCOPE International Fellow in obesity, the World Obesity Federation, 2020
  • FRCP (London), 2017
  • SCOPE National Fellow in obesity, the World Obesity Federation, 2014
  • PhD in sleep, diabetes and microvascular complications, University of Birmingham, 2013
  • CCT in Diabetes and Endocrinology, 2012
  • MMedSci, Master of Medical Sciences, Keele University, 2008
  • MRCP (UK), 2003
  • MD in Medicine, University of Aleppo, Syria 1998

Biography

Dr. Tahrani has published over 150 peer reviewed articles and book chapters and in excess of 150 abstracts. He is regularly invited to speak in many of the leading national and international conferences in USA, Europe and Asia and delivered more than 100 talks.

Dr. Tahrani has won several national and international awards including the Strategic Centre for Obesity Prevention and Education (SCOPE) National Fellowship in 2014 and International Fellowship in 2020 from the World Obesity Federation; The Diabetes UK best primary care poster award 2014, NIHR Clinician Scientist award in 2013; the American Academy of Sleep Medicine (AASM) Sleep Disordered Breathing investigator of the year award in 2013; The Sanofi Aventis Clinical Excellence Award in 2009; the Society for endocrinology presentations award 2009, and a NIHR personal research training fellowship in 2008 in addition to several regional and local awards. He was also nominated to the Nick Hales young investigator award by Diabetes UK and he was elected as a member of Neurodiab (The diabetic neuropathy group of the European Association of the Study of Diabetes (EASD).

He previously served on the clinical committee of The Society for Endocrinology and is currently the diabetes and metabolism section editor for BMC Endocrine disorders and an editorial advisor to BMC Obesity. He is also the obesity and metabolism associate editor for the European Journal of Endocrinology.  Dr Tahrani was the editorial consultant for the type 1 diabetes module of the American College of Physicians.

Dr Tahrani leads a multi-disciplinary research group that include scientists, clinicians, allied health-care professionals, and PhD and Master students. The aims of this research group are to:

  1. examine the impact of sleep-related disorders (including obstructive apnoea) on metabolic health, diabetes and obesity and developing new treatment strategies to reduce the burden of metabolic disorders
  2. manage obesity including: the pharmacological and non-pharmacological, the long-term outcomes of bariatric surgery and other treatment modalities, health service delivery) as well as the managemt of obesity-related comorbidities such as polycystic ovarian syndrome, idiopathic intracranial hypertension and Type 2 diabetes.
  3. improve our understanding of the pathogenesis of diabetes-related microvascular complications (peripheral neuropathy, autonomic neuropathy, nephropathy, foot disease) and to identify new treatment targets and effective screening strategies

In order to achieve the aims above-mentioned, Dr Tahrani group works in close collaboration in the fields of psychology, sleep, nutrition, epidemiology, statistics, sports medicine, hepatology as well as industry, policy makers and patients’ groups. 

What barriers do health professionals face when raising the issue of obesity?

 

Dr Tahrani is a regular reviewer of grants submitted to the Hong Kong Medical Research Council, Wageningen University & Research Foundation in the Netherlands, New Zealand Research Council, Czech Research Council, MRC (UK), Diabetes UK, Biotechnology and Biological Sciences Research Council (BBSRC), Novo Nordisk Research Foundation, The Physiological Society, The Economic and Social Research Council and the NIHR including: Health Technology Assessments (HTA), RfPB, Efficacy and Mechanism Evaluation (EME) and Health Service Delivery evaluations. He is also a regular peer reviewer to several leading journals in the fields of medicine, endocrinology, diabetes and obesity.

Dr. Tahrani was an examiner at the Royal College of Physicians in London and was a member of the organising committee of the European Congress of Obesity 2019, and a faculty member of the Neurodiab 2018 conference.

Postgraduate supervision

Dr Tahrani welcomes PhD and MD students who are interested in working in the fields of sleep, obesity or diabetes mellitus. He has 2 PhD and 7 Master students all finished and passed on time without delay. Currently he has 4 PhD students.

Research

Research aims

  1. Examine the impact of sleep-related disorders (including obstructive apnoea) on metabolic health, diabetes and obesity and developing new treatment strategies to reduce the burden of metabolic disorders
  2. Obesity management including: the pharmacological and non-pharmacological, the long-term outcomes of bariatric surgery and other treatment modalities, health service delivery) as well as the managemt of obesity-related comorbidities such as polycystic ovarian syndrome, idiopathic intracranial hypertension and Type 2 diabetes.
  3. Improve our understanding of the pathogenesis of diabetes-related microvascular complications (peripheral neuropathy, autonomic neuropathy, nephropathy, foot disease) and to identify new treatment targets and effective screening strategies

Research groups and centres

Centre for Endocrinology, Diabetes and Metabolism

Other activities

  • A member of the International Collaboration of Sleep Apnea Cardiovascular Trialists (INCOSACT)
  • A member of the Language Matters Guidelines group
  • A member of the Neurodiab
  • A member of the research committee of the British Sleep Society
  • Lead for Weight Management Research and Diabetic Neuropathy Services at University Hospitals Birmingham NHS Foundation Trust.
  • The Diabetes and Metabolism Section Editor for BMC Endocrine Disorders
  • The Obesity and Metabolism Associate Editor for the European Journal of Endocrinology
  • An editorial board member of Review of Dibaetic Studies, clinical medicine case reports medical journal, the World Journal of Diabetes, Biomed Research International and the Journal of Translational Internal Medicine
  • Grant reviewer for Hong Kong Medical Research Council, Wageningen University & Research Foundation in the Netherlands, New Zealand Research Council, Czech Research Council, MRC (UK), Diabetes UK, Biotechnology and Biological Sciences Research Council (BBSRC), Novo Nordisk Research Foundation, The Physiological Society, The Economic and Social Research Council, National Institute for Health research (UK) funding streams including: Health Technology Assessments (HTA), Research for Patient Benefit (RfPB), Efficacy and Mechanism Evaluation (EME) and Health Service Delivery evaluations.
  • Regular peer reviewer to several leading journal including the Lancet, Lancet diabetes & endocrinology, Annals of internal Medicine, Journal of American College of Cardiology, BMJ, Canadian Medical Association Journal, Annals of Medicine, Thorax, Diabetes Care, Diabetologia, Diabetic Medicine, Clinical Endocrinology, British Journal of General Practice, BMC endocrine disorders, Thyroid, Endocrine Practice, Journal of the American Society of Nephrology, Drug and therapeutic bulletin, Ophthalmology, American Journal of Kidney Disease disorders, Diabetes Research and Clinical Practice, Cardiovascular Diabetologia, BMJ Open Diabetes Research, Journal of clinical sleep medicine,  Emirates Medical Journal, BMJ Open, Diabetes and Vascular Disease Research, PLOS One, PLOS Medicine, and Review of Diabetic Studies amongst others. Dr Tahrani's full peer review profile
  • An expert and clinical advisor to the National Institute for Health Care Excellence (NICE) in England
  • A member of the NIHR RfPB West Midlands Panel
  • A member of NIHR Dissemination Centre
  • Previously a MRCP examiner
  • Previously an editorial consultant for the Type 1 diabetes module provided by the American College of Physicians
  • Previously served as a member of the Clinical committee of the Society of Endocrinology and the West Midlands postgraduate medicine board in the West Midlands Deanery.

Publications

Recent publications

Article

Singhal, R, Wiggins, T, Super, J, Alqahtani, A, Nadler, EP, Ludwig, C, Tahrani, A & Mahawar, K 2021, '30-Day morbidity and mortality of bariatric metabolic surgery in adolescence during the COVID-19 pandemic - The GENEVA study', Pediatric Obesity. https://doi.org/10.1111/ijpo.12832

Wang, J, Cooper, J, Gokhale, K, Acosta-Mena , D, Dhalla , S, Byne , N, Chandan, JS, Anand, A, Okoth, K, Subramanian, A, Bangash, M, Jackson, T, Zemedikun, D, Taverner, T, Hanif, W, Ghosh, S, Narendran, P, Toulis, K, Tahrani, A, Surenthirakumaran, R, Adderley, N, Haroon, S, Khunti, K, Sainsbury, C, Thomas, GN & Nirantharakumar, K 2021, 'Association of metformin with susceptibility to COVID-19 in people with type 2 diabetes', Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.1210/clinem/dgab067

Grech, O, Clouter, A, Mitchell, J, Alimajstorovic, Z, Ottridge, R, Yiangou, A, Roque, M, Tahrani, A, Nicholls, M, Taylor, A, Shaheen, F, Arlt, W, Lavery, G, Shapiro, K, Mollan, S & Sinclair, A 2021, 'Cognitive performance in Idiopathic Intracranial Hypertension and relevance of intracranial pressure', Brain Communications, vol. 3, no. 3, fcab202. https://doi.org/10.1093/braincomms/fcab202

Elliot, L, Frew, E, Mollan, S, Mitchell, J, Yiangou, A, Alimajstorovic, Z, Ottridge, R, Wakerley, B, Thaller, M, Grech, O, Singhal, R, Tahrani, A, Harrison, M, Sinclair, A & Aguiar, M 2021, 'Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: evidence from a single payer health care system', Surgery for Obesity and Related Diseases, vol. 17, no. 7, pp. P1310-1316. https://doi.org/10.1016/j.soard.2021.03.020

Mollan, S, Mitchell, J, Ottridge, R, Aguiar, M, Alimajstorovic, Z, Cartwright, D, Grech, O, Lavery, G, Westgate, C, Vijay, V, Scotton, W, Wakerley, B, Matthews, T, Ansons, A, Hickman, S, Benzimra, J, Rick, C, Singhal, R, Tahrani, A, Brock, K, Frew, E & Sinclair, A 2021, 'Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension: A Randomized Clinical Trial', JAMA Neurology, vol. 78, no. 6, pp. 678-686. https://doi.org/10.1001/jamaneurol.2021.0659

Singhal, R, Tahrani, A, Ludwig, C, Mahawar, K & GENEVA collaborators 2021, 'Global 30-day outcomes after bariatric surgery during the COVID-19 pandemic (GENEVA): an international cohort study', The Lancet Diabetes and Endocrinology, vol. 9, no. 1, 7-9. https://doi.org/10.1016/S2213-8587(20)30375-2

Wang, J, Nirantharakumar, K, Gokhale, K, Tahrani, A, Taverner, T, Thomas, GN & Indranil, D 2021, 'Obesity without metabolic abnormality and incident CKD: a population-based British cohort study', American Journal of Kidney Diseases. https://doi.org/10.1053/j.ajkd.2021.05.008

Yiangou, A, Mitchell, J, Nicholls, M, Chong, YJ, Vijay, V, Wakerley, B, Lavery, G, Tahrani, A, Mollan, S & Sinclair, A 2021, 'Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a substudy of the Idiopathic Intracranial Hypertension Weight randomised controlled trial (IIH:WT)', Journal of Neurology. https://doi.org/10.1007/s00415-021-10700-9

Singh, P, Adderley, N, Hazlehurst, J, Price, M, Tahrani, A, Nirantharakumar, K & Bellary, S 2021, 'Prognostic models for predicting remission of diabetes following bariatric surgery: a systematic review and meta-analysis', Diabetes Care.

Riley, J, Antza, C, Kempegowda, P, Subramanian, A, Chandan, JS, Gokhale, K, Thomas, N, Sainsbury, C, Tahrani, AA & Nirantharakumar, K 2021, 'Social deprivation and incident diabetes-related foot disease in patients with type 2 diabetes: a population-based cohort study', Diabetes Care, vol. 44, no. 3, pp. 731-739. https://doi.org/10.2337/dc20-1027

Aguiar, M, Frew, E, Mollan, S, Mitchell, J, Ottridge, R, Alimajstorovic, Z, Yiangou, A, Singhal, R, Tahrani, A & Sinclair, A 2021, 'The health economic evaluation of bariatric surgery versus a community weight management intervention analysis from the idiopathic intracranial hypertension weight trial (IIH:WT)', Life, vol. 11, no. 5, 409. https://doi.org/10.3390/life11050409

Singh, P, Adderley, N, Subramanian, A, Gokhale, K, Singhal, R, Toulis, K, Bellary, S, Nirantharakumar, K & Tahrani, A 2021, 'The impact of bariatric surgery on incident microvascular complications in patients with type 2 diabetes: a matched controlled population-based retrospective cohort study', Diabetes Care, vol. 44, no. 1, pp. 116-124. https://doi.org/10.2337/dc20-0571

Antza, C, Ottridge, R, Patel, S, Slinn, G, Tearne, S, Nicholls, M, Cooper, B, Ali, A & Tahrani, A 2021, 'The impact of sleep disorders on microvascular complications in patients with type 2 diabetes (SLEEP T2D): the protocol of a cohort study and feasibility randomised control trial', Pilot and Feasibility Studies, vol. 7, no. 1, 80. https://doi.org/10.1186/s40814-021-00817-z

Mollan, S, Tahrani, A & Sinclair, A 2021, 'The potentially modifiable risk factor in idiopathic intracranial hypertension: body weight', Neurology: Clinical Practice. https://doi.org/10.1212/CPJ.0000000000001063

Review article

Pezhman, L, Tahrani, A & Chimen, M 2021, 'Dysregulation of Leukocyte Trafficking in Type 2 Diabetes: Mechanisms and Potential Therapeutic Avenues', Frontiers in cell and developmental biology, vol. 9, 624184. https://doi.org/10.3389/fcell.2021.624184

View all publications in research portal

Expertise

Obesity, sleep apnoea, diabetes